|Bid||0.00 x 900|
|Ask||0.00 x 3200|
|Day's range||37.26 - 37.74|
|52-week range||29.99 - 43.08|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||22.03|
|Earnings date||04 May 2021|
|Forward dividend & yield||1.56 (4.20%)|
|Ex-dividend date||28 Jan 2021|
|1y target est||40.64|
Blood clot concerns lack context, experts say, putting pressure on federal agencies to unpause J&J vaccinations.
Pfizer Inc. (NYSE: PFE) announced today that shareholders and the general public are invited to access its virtual-only 2021 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 22, 2021. As previously disclosed, this year’s meeting will be held virtually due to continued public health concerns related to the COVID-19 pandemic and to support the health and well-being of our shareholders and other meeting participants. We have designed the virtual Annual Meeting to ensure that our shareholders who attend the virtual Annual Meeting will be afforded comparable rights and opportunities to participate as they would at an in-person meeting.
The European Commission approves Bristol Myers' (BMY) Opdivo in combination with Cabometyx for first-line treatment of advanced renal cell carcinoma.